Immunovant (IMVT) Current Taxes (2019)

Immunovant (IMVT) reported Current Taxes of $106000.0 for Q4 2019, up 236.4% quarter-over-quarter from $31510.0 in Q3 2019.

Immunovant (IMVT) Current Taxes (2019) Analysis & Trends

Immunovant has reported Current Taxes for 1 years, with the latest figure at $106000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 10,460.56
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 19.20 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Immunovant 5.71 Bn 5.71 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 106,000.00
Sep 30, 2019 31,510.00
Jun 30, 2019 66,467.00